Financial News

Financial Reports: Johnson & Johnson

Pharmaceutical sales up 6% in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Johnson & Johnson 1Q Revenues: $17.5 billion (+1%) 1Q Earnings: $4.9 billion (+1%) Comments: Pharmaceutical sales were $8.2 billion in the quarter, up 6%, with domestic sales up 13% and international sales down 3%. REMICADE sales were $1.8 billion in the quarter, up 11%. SIMPONI/SIMPONI ARIA sales were $390 million, up 30%. STELARA sales were $735 million, up 34%. INVEGA SUSTENNA/XEPLION/TRINZA sales were $513 million, up 25%. New product sales growth was negatively impacted by lowe...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters